Novel Innovations for Ventricular Assist Device Infection

Area of Science:

• Cardiology
• Infectious Diseases
• Surgical Innovation

Background:

• Device infection is a significant complication of ventricular assist device (VAD) implantation, often necessitating complex management.
• Current treatment options for VAD infections are limited, with antibiotic therapy alone frequently proving insufficient.
• The increasing use of long-term VAD support raises concerns about a potential rise in device-related infections requiring reintervention.

Observation:

• A patient underwent a third left ventricular assist device (LVAD) exchange (fourth device implant) due to recurrent device infection within eight years.
• The patient's history involved multiple VAD implantations and subsequent infections, underscoring the challenges of managing persistent device-related sepsis.
• The surgical approach for the latest exchange involved considerations for preventing future infections.

Findings:

• Repeated device exchange may be required for durable source control in cases of persistent VAD infection.
• The use of the greater omentum in surgical management of VAD infection was explored as a potential strategy to improve outcomes.
• This case illustrates a challenging clinical scenario of recurrent VAD infection necessitating multiple interventions.

Implications:

• Novel surgical techniques are crucial for improving the management of VAD infections and preventing recurrence.
• Further research into the role of tissue flaps, such as the greater omentum, may offer new therapeutic avenues for VAD-related complications.
• Optimizing VAD infection treatment strategies is essential to improve long-term patient outcomes and device longevity.